CG Oncology (CGON) Enterprise Value (2023 - 2025)
CG Oncology's Enterprise Value history spans 3 years, with the latest figure at -$742.2 million for Q4 2025.
- For Q4 2025, Enterprise Value changed 0.02% year-over-year to -$742.2 million; the TTM value through Dec 2025 reached -$742.2 million, changed 0.02%, while the annual FY2025 figure was -$742.2 million, 0.02% changed from the prior year.
- Enterprise Value reached -$742.2 million in Q4 2025 per CGON's latest filing, down from -$680.3 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$187.7 million in Q4 2023 to a low of -$742.2 million in Q4 2025.
- Average Enterprise Value over 3 years is -$595.7 million, with a median of -$661.1 million recorded in 2025.
- Peak YoY movement for Enterprise Value: plummeted 295.37% in 2024, then dropped 0.02% in 2025.
- A 3-year view of Enterprise Value shows it stood at -$187.7 million in 2023, then tumbled by 295.37% to -$742.0 million in 2024, then dropped by 0.02% to -$742.2 million in 2025.
- Per Business Quant, the three most recent readings for CGON's Enterprise Value are -$742.2 million (Q4 2025), -$680.3 million (Q3 2025), and -$661.1 million (Q2 2025).